Pesquisas alternativas:
daily compared » early compared (Expandir a Pesquisa), elderly compared (Expandir a Pesquisa)
nasal compass » neural compass (Expandir a Pesquisa), visual compass (Expandir a Pesquisa), nasal mass (Expandir a Pesquisa)
compared can » compared case (Expandir a Pesquisa), compared a (Expandir a Pesquisa), compared law (Expandir a Pesquisa)
compass can » compass a (Expandir a Pesquisa), company can (Expandir a Pesquisa), compass ion (Expandir a Pesquisa)
como can » como canal (Expandir a Pesquisa), como canon (Expandir a Pesquisa), como cande (Expandir a Pesquisa)
can net » can next (Expandir a Pesquisa), can new (Expandir a Pesquisa), dan net (Expandir a Pesquisa)
a daily » _ daily (Expandir a Pesquisa)
can non » dan non (Expandir a Pesquisa), than non (Expandir a Pesquisa), can ngoc (Expandir a Pesquisa)
3 nasal » 3d nasal (Expandir a Pesquisa), 31 nasal (Expandir a Pesquisa), _ nasal (Expandir a Pesquisa)
daily compared » early compared (Expandir a Pesquisa), elderly compared (Expandir a Pesquisa)
nasal compass » neural compass (Expandir a Pesquisa), visual compass (Expandir a Pesquisa), nasal mass (Expandir a Pesquisa)
compared can » compared case (Expandir a Pesquisa), compared a (Expandir a Pesquisa), compared law (Expandir a Pesquisa)
compass can » compass a (Expandir a Pesquisa), company can (Expandir a Pesquisa), compass ion (Expandir a Pesquisa)
como can » como canal (Expandir a Pesquisa), como canon (Expandir a Pesquisa), como cande (Expandir a Pesquisa)
can net » can next (Expandir a Pesquisa), can new (Expandir a Pesquisa), dan net (Expandir a Pesquisa)
a daily » _ daily (Expandir a Pesquisa)
can non » dan non (Expandir a Pesquisa), than non (Expandir a Pesquisa), can ngoc (Expandir a Pesquisa)
3 nasal » 3d nasal (Expandir a Pesquisa), 31 nasal (Expandir a Pesquisa), _ nasal (Expandir a Pesquisa)
21
Por Dupoiron, D., Stachowiak, A., Loewenstein, O., Ellery, A., Kremers, W., Bosse, B., Hopp, M.
Publicado no Eur J Pain (2017)
“.../80 mg PR compared with oxycodone prolonged‐release formulation (OxyPR) in a randomised controlled...”Publicado no Eur J Pain (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
22
Por Dunlay, Shannon M., Manemann, Sheila M., Chamberlain, Alanna M., Cheville, Andrea L., Jiang, Ruoxiang, Weston, Susan A., Roger, Véronique L.
Publicado no Circ Heart Fail (2015)
“... a mean (SD) follow-up of 3.2 (2.4) years, 614 (54.4%) patients had died. Mortality increased...”Publicado no Circ Heart Fail (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
23
“... remains a powerful tool for preventing or mitigating influenza outbreaks. Yet, vaccine supplies and daily...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
24
“... admission, any intervention made, and their disposal from A&E. Routine hospital data compared the mean daily...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
25
Por Dupoiron, D., Stachowiak, A., Loewenstein, O., Ellery, A., Kremers, W., Bosse, B., Hopp, M.
Publicado no Eur J Pain (2017)
“... function, pain, quality of life (QoL) and safety of OXN PR up to 180/90 mg daily were evaluated in a 24...”Publicado no Eur J Pain (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
26
Por Pastore, Antonio Luigi, Palleschi, Giovanni, Fuschi, Andrea, Silvestri, Luigi, Al Salhi, Yazan, Costantini, Elisabetta, Zucchi, Alessandro, Petrozza, Vincenzo, de Nunzio, Cosimo, Carbone, Antonio
Publicado no BMC Cancer (2015)
“... was further divided into three therapeutic subgroups: Group A (100 mg of aspirin, daily for at least two years...”Publicado no BMC Cancer (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
27
Por Blauvelt, A., Reich, K., Mehlis, S., Vanaclocha, F., Sofen, H., Abramovits, W., Zhao, Y., Gilloteau, I., Davenport, E., Williams, N., Guana, A., Tyring, S.
Publicado no J Eur Acad Dermatol Venereol (2017)
“... the CLEAR study, a phase 3b double‐blind study comparing the efficacy and safety of secukinumab vs...”Publicado no J Eur Acad Dermatol Venereol (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
28
Por Mortazavi, S. M. J., Rahimi, S., Mosleh-Shirazi, M. A., Arjomandi, M., Soleimani, A., Koohi Hossein-abadi, O., Haghani, M., Alavi, M.
Publicado no J Biomed Phys Eng (2015)
“... and Vit A. Group 4; all three vitamins. Group V; an over-the-counter multivitamin. Group VI; none...”Publicado no J Biomed Phys Eng (2015)
Obter o texto integral
Obter o texto integral
Artigo
29
“... (American stop smoking intervention study) states as compared with non-ASSIST states.
METHODS—Local tobacco...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
30
Por Fogh, S, Schapira, A, Bygbjerg, I C, Jepsen, S, Mordhorst, C H, Kuijlen, K, Ravn, P, Rønn, A, Gøtzsche, P C
Publicado em 1988
“... of chloroquine phosphate 500 mg weekly with proguanil hydrochloride 200 mg daily was compared with the efficacy...”Publicado em 1988
Obter o texto integral
Obter o texto integral
Artigo
31
32
Por Ihlen, Espen A. F., van Schooten, Kimberley S., Bruijn, Sjoerd M., Pijnappels, Mirjam, van Dieën, Jaap H.
Publicado no Front Physiol (2017)
“... step cycle. Here we apply a general non-exponential construct of gait stability, called fractional...”Publicado no Front Physiol (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
33
Por Cleutjens, Fiona A H M, Wouters, Emiel F M, Dijkstra, Jeanette B, Spruit, Martijn A, Franssen, Frits M E, Vanfleteren, Lowie E G W, Ponds, Rudolf W H M, Janssen, Daisy J A
Publicado em 2014
“... and the relationship with cognitive and daily functioning will be explored. METHODS AND ANALYSIS: A longitudinal...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
34
Por Sevillano, Claudia A, Nicolaiciuc, Catalin V, Molist, Francesc, Pijlman, Jeroen, Bergsma, Rob
Publicado no J Anim Sci (2018)
Assuntos:
“...Non Ruminant Nutrition...”Publicado no J Anim Sci (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
35
Por Kass-Hout, Taha A, Xu, Zhiheng, McMurray, Paul, Park, Soyoun, Buckeridge, David L, Brownstein, John S, Finelli, Lyn, Groseclose, Samuel L
Publicado em 2012
“... combined with EARS to analyze automatically daily ED-based ILI data, a significant increase was detected...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
36
Por Jha, Manish K, Teer, Raymond B, Minhajuddin, Abu, Greer, Tracy L, Rush, A John, Trivedi, Madhukar H
Publicado no Neuropsychiatr Dis Treat (2017)
“... rates of remission at 3 and 7 months as compared to moderate or severe activity impairment levels even...”Publicado no Neuropsychiatr Dis Treat (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
37
“... Parkinson’s disease is levodopa considered a gold standard. In addition levodopa can also be used as a...”
Obter o texto integral
Obter o texto integral
Artigo
38
“.... Material and methods. The trial involved 11 Russian cities. This Russian multi-center, non-comparative...”
Obter o texto integral
Obter o texto integral
Artigo
39
“... daily sustained release dosage form. A hydrophilic matrix-based tablet using different concentrations...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
40
“... year. The market of non-alcoholic and functional beverages (FB), which can help for solving...”
Obter o texto integral
Obter o texto integral
Artigo